awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33435622-031E68DD-2AFC-49DC-8B84-3BF4BBF7E2F7
Q33435622-031E68DD-2AFC-49DC-8B84-3BF4BBF7E2F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33435622-031E68DD-2AFC-49DC-8B84-3BF4BBF7E2F7
High clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.
P2860
Q33435622-031E68DD-2AFC-49DC-8B84-3BF4BBF7E2F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33435622-031E68DD-2AFC-49DC-8B84-3BF4BBF7E2F7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9bac3e53bf3fda02e34a53ad65ca0e7ccddeab3e
P2860
Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion.